University College of London
London WC1N 3BG
1 studies enrolling now · 5 studies all time
What they study most
Cerebral Amyloid Angiopathy, Friedreich Ataxia, Huntington's Disease, Inclusion Body Myositis
Studies at this site
- Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort — Recruiting now
- A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia — Completed
- Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial — Stopped early
- Study of Arimoclomol in Inclusion Body Myositis (IBM) — Completed
- Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy — Completed